Blepharitis Market DelveInsight’s insight report provides a comprehensive understanding of Blepharitis Market size by treatment, epidemiology, emerging therapies, market share of different therapies, and the current and forecast Blepharitis Market size from 2019 to 2032, segmented into the 7MM (US, EU5 ( regions Germany, France, Italy, Spain and Great Britain) and Japan).

Overview of Blepharitis

Blepharitis is an inflammation of the eyelids that causes them to become red, irritated, itchy, and cause scaly scales to form on the eyelashes. It is a chronic external eye condition that causes red, burning and irritated eyes that does not seriously damage the eyes but can be very uncomfortable. It can be caused by either bacteria or a skin condition such as scalp dandruff or rosacea.

Download sample report- https://www.delveinsight.com/sample-request/blepharitis-market

Regions covered in the report

• The United States
• EU5 (Germany, France, Italy, Spain and UK)
• Japan

Key highlights of the Blepharitis market report

• According to the NIH, blepharitis is more common in people over the age of 50.
• According to the Atlas study (2022), more than half of patients (51%) have had signs and symptoms of Demodex blepharitis for more than 4 years, and 58% of patients have never been diagnosed with blepharitis.
• In a study by Lemp et al. (2009) Blepharitis symptoms are very common in the US population, with younger individuals reporting symptoms more frequently than older individuals.

Insights into blepharitis epidemiology

In a survey conducted in the United States by Duncan et al., (2015), 37% to 47% of the patients who visited the respondents were diagnosed with blepharitis. In a 2009 US survey, 37% of patients seen by an ophthalmologist and 47% of patients seen by an ophthalmologist had evidence of blepharitis (NIH).

Segmentation of blepharitis epidemiology in the 7MM

• Blepharitis Common cases
• Type-Specific Blepharitis – Prevalent …